DRUG DEVELOPMENT PIPELINE

Back to the Drug Development Pipeline

Glutathione

Phase Two

Phase Two

Therapeutic Approach

Nutritional-GI

Glutathione is an antioxidant that is important to the normal functioning of the intestine and lungs. Glutathione levels have been shown to be lower in people with CF. Oral glutathione may improve growth and decrease gut inflammation in children with CF.

Status

A phase 2 study will begin in 2017 to test the safety and effectiveness of oral glutathione in children with CF.

Sponsor

This program is funded by Cystic Fibrosis Foundation Therapeutics (CFFT). It is being conducted within the Cystic Fibrosis Foundation's Therapeutics Development Network.

Contact us about Glutathione >